EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Integrated bioinformatics analysis and clinical validation identifies TNFSF14 and CD40 as novel biomarkers for chronic kidney disease progression and tubulointerstitial injury

Xiameng Gu, Yuqing Lu, Haonan Sha, Hanlu Zhang, Hongxin Chen, Mengyue Qiu, Xiaolan Chen

International Urology and Nephrology · 2026

DOI: 10.1007/s11255-026-05138-9 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift International Urology and Nephrology, 2026. Verfasst von Xiameng Gu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Affiliated Hospital of Nantong University, Jiangsu, 226001, China. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, CD40 Antigens, Tumor Necrosis Factor Ligand Superfamily Member 14. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Project of Nantong City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is a global public health burden characterized by irreversible renal function loss and progressive fibrosis. Non-invasive biomarkers reflecting intra-renal inflammation and early tubulointerstitial injury remain an unmet clinical need. We combined bioinformatics analysis with clinical validation to characterize two immune-related genes, TNFSF14 and CD40, in CKD progression.

Methods

Two independent CKD transcriptomic datasets (GSE66494, n = 61; GSE97709, n = 48) were retrieved from the GEO database. Differentially Expressed Genes (DEGs) were screened with FDR adjustment. Clinical validation was performed in 140 CKD patients (KDIGO Stages I–V) and 60 healthy controls. TNFSF14 and CD40 levels were quantified in serum/urine via ELISA, with intra-renal expression assessed via immunofluorescence in 80 biopsy specimens. Multivariable regression was used to evaluate independent predictive value.

Results

TNFSF14 and CD40 were identified as core hub genes enriched in the TNF signaling pathway. Both markers were significantly elevated in serum/urine of CKD patients (Adjusted P < 0.05), with upregulation localized to renal tubular epithelial cells. Urinary levels increased in a CKD stage-dependent manner, positively correlating with serum creatinine/BUN and inversely with eGFR. Urinary TNFSF14 and CD40 were independent predictors of advanced CKD, with a combined diagnostic model achieving an AUC of 0.892 (95% CI: 0.851–0.933).

Conclusions

TNFSF14 and CD40 are robust molecular signatures of tubulointerstitial injury, and their urinary levels serve as non-invasive biomarkers for CKD detection and risk stratification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicCD40 AntigensTumor Necrosis Factor Ligand Superfamily Member 14HumansBiomarkersDisease ProgressionFemaleMaleComputational BiologyMiddle AgedAdultKidney TubulesNephritis, Interstitial

Stichwörter der Autor:innen

BioinformaticsBiomarkerCD40Chronic kidney diseaseRenal fibrosisTNFSF14Tubulointerstitial injuryUrinary biomarkers

Substanzen

BiomarkersCD40 AntigensTumor Necrosis Factor Ligand Superfamily Member 14TNFSF14 protein, human

Autor:innen und Institutionen

  • Department of Nephrology, Affiliated Hospital of Nantong University, Jiangsu, 226001, China.
  • Department of Pediatric Surgery, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany.
  • Department of Nephrology, Affiliated Hospital of Nantong University, Jiangsu, 226001, China. chenxl8448@sina.com.

Förderung

  • Science and Technology Project of Nantong City

Zitieren

APA

Gu, X., Lu, Y., Sha, H., Zhang, H., Chen, H., Qiu, M., & Chen, X. (2026). Integrated bioinformatics analysis and clinical validation identifies TNFSF14 and CD40 as novel biomarkers for chronic kidney disease progression and tubulointerstitial injury. International Urology and Nephrology. https://doi.org/10.1007/s11255-026-05138-9

Vancouver

Gu X, Lu Y, Sha H, Zhang H, Chen H, Qiu M, et al. Integrated bioinformatics analysis and clinical validation identifies TNFSF14 and CD40 as novel biomarkers for chronic kidney disease progression and tubulointerstitial injury. International Urology and Nephrology. 2026. doi:10.1007/s11255-026-05138-9

BibTeX
@article{Gu2026,
  author = {Gu, Xiameng and Lu, Yuqing and Sha, Haonan and Zhang, Hanlu and Chen, Hongxin and Qiu, Mengyue and Chen, Xiaolan},
  title = {Integrated bioinformatics analysis and clinical validation identifies TNFSF14 and CD40 as novel biomarkers for chronic kidney disease progression and tubulointerstitial injury},
  journal = {International Urology and Nephrology},
  year = {2026},
  doi = {10.1007/s11255-026-05138-9}
}
Kostenlos starten →